Literature DB >> 24725226

Biphasic anaphylactic reactions: occurrence and mortality.

M Rohacek1, H Edenhofer, A Bircher, R Bingisser.   

Abstract

BACKGROUND: Monitoring after complete resolution of anaphylactic reactions is recommended. The aim of this study was to define the occurrence of biphasic - and clinically important biphasic - anaphylactic reactions, the number of transfers to intensive care units (ICU) because of anaphylaxis, and the number of deaths within 10 days of presentation to the emergency department (ED).
METHODS: Clinical records of patients visiting the ED of a tertiary care hospital were analysed retrospectively. Hospital databases, direct contact with patients and caregivers, and the Internet were used to obtain mortality rates.
RESULTS: Of 259 557 ED presentations from February 2001 through to August 2013, 1334 (0.51%) episodes of allergic reactions were detected, and 532 (0.20%) episodes in 495 patients fulfilled the definition of anaphylaxis. In 227 (44.8%) episodes, the length of hospital stay was ≥8 h (median 22 h, IQR 16-24). There were 507 uniphasic and 25 (4.5%) biphasic anaphylactic reactions. Twelve (2.3%) were clinically important, including 2 (0.36%) that occurred during hospital stay, one of whom (0.19%) was transferred to ICU for shock. No risk factors for biphasic reactions could be found. Eight patients were lost to follow-up. There were no deaths during the 10-day follow-up.
CONCLUSION: Biphasic anaphylactic reactions, especially clinically important ones, occurred rarely, and no mortality was found, whether the monitoring was for ≥8 h or for <8 h. Our study could motivate physicians to consider discharging patients after complete resolution of an anaphylactic reaction and to dispense with prolonged monitoring.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  anaphylaxis; epidemiology

Mesh:

Year:  2014        PMID: 24725226     DOI: 10.1111/all.12404

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  16 in total

Review 1.  The Epidemiology of Anaphylaxis.

Authors:  Joyce E Yu; Robert Y Lin
Journal:  Clin Rev Allergy Immunol       Date:  2018-06       Impact factor: 8.667

2.  Biphasic and protracted anaphylaxis to iodinated contrast media.

Authors:  Tae-Hyung Kim; Soon Ho Yoon; Suh-Young Lee; Young Hun Choi; Chang Min Park; Hye-Ryun Kang; Sang-Heon Cho
Journal:  Eur Radiol       Date:  2017-09-27       Impact factor: 5.315

Review 3.  Anaphylaxis.

Authors:  Daniel LoVerde; Onyinye I Iweala; Ariana Eginli; Guha Krishnaswamy
Journal:  Chest       Date:  2017-08-08       Impact factor: 9.410

4.  Persistent, refractory, and biphasic anaphylaxis: A multidisciplinary Delphi study.

Authors:  Timothy E Dribin; Hugh A Sampson; Carlos A Camargo; David C Brousseau; Jonathan M Spergel; Mark I Neuman; Marcus Shaker; Ronna L Campbell; Kenneth A Michelson; Susan A Rudders; Amal H Assa'ad; Kimberly A Risma; Mariana Castells; Lynda C Schneider; Julie Wang; Juhee Lee; Rakesh D Mistry; David Vyles; Lisa M Vaughn; Daniel J Schumacher; John K Witry; Shiv Viswanathan; Erica M Page; David Schnadower
Journal:  J Allergy Clin Immunol       Date:  2020-08-24       Impact factor: 10.793

Review 5.  Anaphylaxis in children.

Authors:  Karen S Farbman; Kenneth A Michelson
Journal:  Curr Opin Pediatr       Date:  2016-06       Impact factor: 2.856

6.  Inpatient interventions are infrequent during pediatric hospitalizations for food-induced anaphylaxis.

Authors:  Susan A Rudders; Sunday Clark; Carlos A Camargo
Journal:  J Allergy Clin Immunol Pract       Date:  2017-06-03

7.  Reducing Hospitalization Rates for Children With Anaphylaxis.

Authors:  Karen S Farbman; Kenneth A Michelson; Mark I Neuman; Timothy E Dribin; Lynda C Schneider; Anne M Stack
Journal:  Pediatrics       Date:  2017-06       Impact factor: 7.124

8.  Identification of children with anaphylaxis at low risk of receiving acute inpatient therapies.

Authors:  Timothy E Dribin; Kenneth A Michelson; Michael C Monuteaux; Anne M Stack; Karen S Farbman; Lynda C Schneider; Mark I Neuman
Journal:  PLoS One       Date:  2019-02-07       Impact factor: 3.240

9.  Should adrenaline be used in patients with hemodynamically stable anaphylaxis? Incident case control study nested within a retrospective cohort study.

Authors:  Byuk Sung Ko; Ji Yeon Kim; Dong-Woo Seo; Won Young Kim; Jae Ho Lee; Aziz Sheikh; David W Bates
Journal:  Sci Rep       Date:  2016-02-03       Impact factor: 4.379

10.  Global Trends in Anaphylaxis Epidemiology and Clinical Implications.

Authors:  Paul J Turner; Dianne E Campbell; Megan S Motosue; Ronna L Campbell
Journal:  J Allergy Clin Immunol Pract       Date:  2019-11-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.